These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37298091)

  • 21. Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).
    Ma F; Li H; Wang H; Shi X; Fan Y; Ding X; Lin C; Zhan Q; Qian H; Xu B
    Cancer Lett; 2014 Oct; 353(2):153-9. PubMed ID: 25130168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to trastuzumab and investigation of expression profiles of matrix metalloproteinase-related proteins in primary breast cancer stem cells.
    Koygun GK; Kars MD; Emsen A; Artac H; Aksoy F; Cakir M; Tavli L; Artac M
    Clin Exp Med; 2021 Aug; 21(3):447-456. PubMed ID: 33471244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.
    Wei L; Liu TT; Wang HH; Hong HM; Yu AL; Feng HP; Chang WW
    Breast Cancer Res; 2011 Oct; 13(5):R101. PubMed ID: 22023707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
    Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
    J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy-Resistant Breast Cancer Cells Enhance Tumor Progression by Enhancing Premetastatic Niche Formation through the HIF-1α-LOX Axis.
    Ko YS; Rugira T; Jin H; Joo YN; Kim HJ
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
    Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
    Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses.
    Azzam DJ; Zhao D; Sun J; Minn AJ; Ranganathan P; Drews-Elger K; Han X; Picon-Ruiz M; Gilbert CA; Wander SA; Capobianco AJ; El-Ashry D; Slingerland JM
    EMBO Mol Med; 2013 Oct; 5(10):1502-22. PubMed ID: 23982961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
    Farnie G; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells.
    Burnett JP; Lim G; Li Y; Shah RB; Lim R; Paholak HJ; McDermott SP; Sun L; Tsume Y; Bai S; Wicha MS; Sun D; Zhang T
    Cancer Lett; 2017 May; 394():52-64. PubMed ID: 28254410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model.
    Rossini A; Giussani M; Giacomini A; Guarnotta C; Tagliabue E; Balsari A
    Breast Cancer Res Treat; 2012 Nov; 136(2):457-67. PubMed ID: 23053664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2.
    Koh SY; Moon JY; Unno T; Cho SK
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.
    Hwang-Verslues WW; Kuo WH; Chang PH; Pan CC; Wang HH; Tsai ST; Jeng YM; Shew JY; Kung JT; Chen CH; Lee EY; Chang KJ; Lee WH
    PLoS One; 2009 Dec; 4(12):e8377. PubMed ID: 20027313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.
    Thiagarajan PS; Hitomi M; Hale JS; Alvarado AG; Otvos B; Sinyuk M; Stoltz K; Wiechert A; Mulkearns-Hubert E; Jarrar A; Zheng Q; Thomas D; Egelhoff T; Rich JN; Liu H; Lathia JD; Reizes O
    Stem Cells; 2015 Jul; 33(7):2114-2125. PubMed ID: 25827713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.
    Leccia F; Del Vecchio L; Mariotti E; Di Noto R; Morel AP; Puisieux A; Salvatore F; Ansieau S
    Mol Cancer; 2014 Sep; 13():213. PubMed ID: 25216750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation.
    Wang D; Naydenov NG; Dozmorov MG; Koblinski JE; Ivanov AI
    Breast Cancer Res; 2020 Jan; 22(1):3. PubMed ID: 31910867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.
    Costa CD; Justo AA; Kobayashi PE; Story MM; Palmieri C; Laufer Amorim R; Fonseca-Alves CE
    Int J Biochem Cell Biol; 2019 Mar; 108():21-28. PubMed ID: 30633985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel.
    Gangapuram M; Mazzio EA; Redda KK; Soliman KFA
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
    Rappa G; Lorico A
    Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.
    Louie E; Nik S; Chen JS; Schmidt M; Song B; Pacson C; Chen XF; Park S; Ju J; Chen EI
    Breast Cancer Res; 2010; 12(6):R94. PubMed ID: 21067584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.